CHOP’s Breakthrough Cancer Immunotherapy Program Receives Generous Grant from the Emily Whitehead Foundation
Apr 17, 2018
Emily Whitehead, the first pediatric patient to receive CAR T-cell therapy, and her family honor the CHOP team who saved her life with a $250,000 research grant to expand the use of the therapy for relapsed or refractory ALL.